Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Most relevant news about TEVA PHARMACEUTICAL INDUST
06/20GLOBAL CARCINOID SYNDROME MANAGEMENT : The research provide Industry Overview, M..
AQ
06/20TEVA PHARMACEUTICAL INDUSTRIES : Provides Update on Clinical Trial of Fremanezum..
AQ
06/15UK's Indivior will fight U.S. FDA's approval for copycat drug
RE
06/15TEVA PHARMACEUTICAL INDUSTRIES : Provides Update on Clinical Trial of Fremanezum..
BU
06/05TEVA PHARMACEUTICAL INDUSTRIES : diffuse un sondage dévoilant les besoins des ai..
AQ
06/05TEVA PHARMACEUTICAL INDUSTRIES : Releases Survey Highlighting Needs of Caregiver..
AQ
06/04Aimovig price improves ICER's migraine outlook
AQ
06/03CITI : Limit exposure to Teva bonds
AQ
05/28MANAGEMENT TRACKS : ISA, ImCheck, ArQule
AQ
05/23TEVA PHARMACEUTICAL INDUSTRIES : FDA to respond to Teva migraine drug applicatio..
AQ
05/23TEVA PHARMACEUTICAL INDUSTRIES : Confirms September PDUFA Date for Fremanezumab
BU
05/21ACTELION : Teva on FDA name and shame list
AQ
05/18TEVA PHARMACEUTICAL INDUSTRIES : CORRECTING and REPLACING Teva Announces Publica..
PU
05/18FDA approves Aimovig as first CGRP inhibitor for migraines
AQ
05/18Hikma reaffirms full-year revenue forecast, cites better generics business
RE
More most relevant news
All news about TEVA PHARMACEUTICAL INDUST
06/20GLOBAL CARCINOID SYNDROME MANAGEMENT : The research provide Industry Overview, M..
AQ
06/20TEVA PHARMACEUTICAL INDUSTRIES : Provides Update on Clinical Trial of Fremanezum..
AQ
06/18TEVA PHARMACEUTICAL INDUSTRIES : Negative trial result hardly dents Teva share p..
AQ
06/15UK's Indivior will fight U.S. FDA's approval for copycat drug
RE
06/15TEVA PHARMACEUTICAL INDUSTRIES : Provides Update on Clinical Trial of Fremanezum..
BU
06/11TEVA PHARMACEUTICAL INDUSTRIES LIMIT : Today's Research Reports on Trending Tick..
AC
06/06TEVA PHARMACEUTICAL INDUSTRIES LTD : Submission of Matters to a Vote of Security..
AQ
06/05TEVA PHARMACEUTICAL INDUSTRIES : diffuse un sondage dévoilant les besoins des ai..
AQ
06/05TEVA PHARMACEUTICAL INDUSTRIES : Releases Survey Highlighting Needs of Caregiver..
AQ
06/04Aimovig price improves ICER's migraine outlook
AQ
More news
Sector news : Pharmaceuticals - NEC
06/22Federal Judge Gives Lilly Win on Alimta Regimen Patent
DJ
06/22JOHNSON & JOHNSON : Remakes Top Leadership -- Update
DJ
06/22JOHNSON & JOHNSON : Worldwide Chairman Peterson to Retire
DJ
06/22SHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
06/22Roche to Appoint James Sabry as Head of Partnering
DJ
06/21LONDON MARKETS: FTSE 100 Drops As Oil Shares Extend Losses; Pound Rallies On ..
DJ
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
06/19Tricida Prepares For $175 Million U.S. IPO 
06/18Bear case on Teva weakens further? 
06/18Premarket analyst action - healthcare 
06/18YOUR DAILY PHARMA SCOOP : Selecta Bio Reports Positive, Acceleron And Atara Move.. 
06/18Teva Fails Late-Stage Trial In Migraine Trial 
06/15Ovid's De-Risked Drug Primed For Phase II Readout 
Latest Tweets
12:59aTeva Pharmaceutical Industries $TEVA Bonds Trading 0.8% Higher  
06/22Teva Pharmaceutical Industries $TEVA Debt Trading 0.8% Higher  
06/21$4.74 Billion in Sales Expected for Teva Pharmaceutical Industries Ltd $TEVA .. 
06/20Teva Pharmaceutical Industries $TEVA Stock Rating Upgraded by Wells Fargo &am.. 
06/19Teva Pharmaceutical Industries is the winner of the Klaus Tschira Human Resou..
2
More tweets
Qtime:56
Financials ($)
Sales 2018 19 600 M
EBIT 2018 -
Net income 2018 -
Debt 2018 -
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales 2018 1,26x
Capi. / Sales 2019 1,26x
Capitalization 24 614 M
Chart TEVA PHARMACEUTICAL INDUST
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Technical analysis trends TEVA PHARMACEUTICAL INDUST
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 19,5 $
Spread / Average Target -20%
Managers
NameTitle
Kåre Schultz President, Chief Executive Officer & Director
Sol J. Barer Chairman
Carlo de Notaristefani Executive Vice President-Global Operations
Michael McClellan Chief Financial Officer & Executive Vice President
Amir Elstein Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED34.92%24 614
JOHNSON & JOHNSON-12.27%329 475
PFIZER0.22%213 568
NOVARTIS-9.42%191 991
ROCHE HOLDING LTD.-12.58%191 785
MERCK AND COMPANY8.90%165 373